Sell Torrent Pharma, target Rs 1180: Edelweiss Financial Services
Sell Torrent Pharmaceuticals Ltd. at a price target of Rs 1180.0 and a stop loss at Rs 1325.0 from entry point
Updated:
Edelweiss Financial Services has sell call on Torrent Pharmaceuticals Ltd. with an intra-day target price of Rs 1180.The current market price of Torrent Pharmaceuticals Ltd. is Rs 1248.25. Edelweiss Financial Services recommended to keep stoploss at Rs 1325.0 .
Torrent Pharmaceuticals Ltd., incorporated in the year 1972, is a largecap company (with a market cap of ₹ 21407.68 crore) operating in Pharmaceuticals and health care sector.
Torrent Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed ₹ 5301.65 Cr to Sales Value (97.46 % of Total Sales), Export Incentives which contributed ₹ 122.36 Cr to Sales Value (2.24 % of Total Sales), Other Operating Income which contributed ₹ 15.11 Cr to Sales Value (0.27 % of Total Sales) and Income from License & Others ( Enter.) which contributed ₹ .33 Cr to Sales Value (0.00 % of Total Sales)for the year ending 31-Mar-2016.
For the quarter ended 31-12-2016, the company has reported a Consolidated sales of ₹ 1413.00 Cr., up .50% from last quarter Sales of ₹ 1406.00 Cr. and down 6.92% from last year same quarter Sales of ₹ 1518.00 Cr. Company has reported net profit after tax of ₹ 229.00 Cr. in latest quarter. The company’s CEO is Mr.Samir Mehta. It's Board of Directors include Dr.Chaitanya Dutt, Mr.Ashok Modi, Mr.Haigreve Khaitan, Mr.Mahesh Agrawal, Mr.Markand Bhatt, Mr.Pradeep Bhargava, Mr.Samir Mehta, Mr.Shailesh Haribhakti, Mr.Sudhir Mehta, Mrs.Renu Challu, Prof.Ashish Nanda, Mr.Mahesh Agrawal. Company has its registered office at Torrent House,, Off. Ashram Road, Ahmedabad, 380009, Gujarat. Company has Deloitte Haskins & Sells as its auditors. As on 31-03-2017, the company has a total of 169,222,720 shares outstanding.
Torrent Pharmaceuticals Ltd., incorporated in the year 1972, is a largecap company (with a market cap of ₹ 21407.68 crore) operating in Pharmaceuticals and health care sector.
Torrent Pharmaceuticals Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed ₹ 5301.65 Cr to Sales Value (97.46 % of Total Sales), Export Incentives which contributed ₹ 122.36 Cr to Sales Value (2.24 % of Total Sales), Other Operating Income which contributed ₹ 15.11 Cr to Sales Value (0.27 % of Total Sales) and Income from License & Others ( Enter.) which contributed ₹ .33 Cr to Sales Value (0.00 % of Total Sales)for the year ending 31-Mar-2016.
For the quarter ended 31-12-2016, the company has reported a Consolidated sales of ₹ 1413.00 Cr., up .50% from last quarter Sales of ₹ 1406.00 Cr. and down 6.92% from last year same quarter Sales of ₹ 1518.00 Cr. Company has reported net profit after tax of ₹ 229.00 Cr. in latest quarter. The company’s CEO is Mr.Samir Mehta. It's Board of Directors include Dr.Chaitanya Dutt, Mr.Ashok Modi, Mr.Haigreve Khaitan, Mr.Mahesh Agrawal, Mr.Markand Bhatt, Mr.Pradeep Bhargava, Mr.Samir Mehta, Mr.Shailesh Haribhakti, Mr.Sudhir Mehta, Mrs.Renu Challu, Prof.Ashish Nanda, Mr.Mahesh Agrawal. Company has its registered office at Torrent House,, Off. Ashram Road, Ahmedabad, 380009, Gujarat. Company has Deloitte Haskins & Sells as its auditors. As on 31-03-2017, the company has a total of 169,222,720 shares outstanding.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
